We are available 24/7


Tepezza Claim Eligibility For Injured Consumers

How Tepezza Causes You Injuries

Tepezza is the first prescription drug approved by the FDA to treat thyroid eye disease, a condition in which the eye muscles, tear glands, eyelids, and fatty tissue behind the eye are inflamed. This autoimmune disease causes swollen, red eyes, double vision, and eye bulging. Recently, it was found that using teprotumumab, the active ingredient in Tepezza, may lead to hearing loss and tinnitus. According to the Endocrine Society, up to 65% of those who use the medication regularly, specifically four times a day, come to struggle with some hearing loss. Tepezza may cause potentially irreversible hearing loss, ranging from mild to severe, according to a study from Ophthalmic Plastic and Reconstructive Surgery.

Up to 85% of Tepezza users might experience hearing loss, according to a study from the Journal of the Endocrine Society, information that came to light just one year after the drug was approved by the FDA. While the label contains warnings for side effects such as infusion reactions, exacerbation of preexisting irritable bowel disease, and hyperglycemia, it fails to address hearing loss or tinnitus. The study also found that the most common symptoms Tepezza use had caused were a sensation of ear plugging and muffled hearing. Although the drug is a promising new therapy for moderate to severe thyroid eye disease, hearing loss and tinnitus are concerning adverse effects that might be irreversible.

Tepezza Manufacturers

The manufacturer of Tepezza is Horizon Therapeutics USA Inc. It is located in Chicago, Illinois, but the main headquarters of the company are in Dublin, Ireland. The pharmaceutical manufacturer made $3.23 billion in drug sales in 2021. Horizon Therapeutics USA Inc. was founded in 2008 with the mission of delivering "medicines for rare, autoimmune and severe inflammatory diseases." The CEO of the company is Timothy P. Walbert, diagnosed himself with a rare autoimmune disease.

Tepezza Side Effects that Can Lead to Claims

If you developed hearing loss or tinnitus as a result of using Tepezza, you might be eligible to file a claim with the manufacturer, which can result in financial compensation. Our team will carefully review your medical records to determine whether you are a potential claimant. Patients who have taken Tepezza regularly and struggle with the following are likely to be entitled to compensation:

  • hearing loss
  • tinnitus

However, the drug was found to cause other hearing-related side effects for which you might qualify to file a claim. Still, hearing loss and tinnitus have the strongest association with Tepezza use. Other studies discovered that, in addition to these problems, Tepezza users experienced:

  • ear plugging sensations
  • heightened hearing of their voice
  • damage to the inner ear
  • patulous eustachian tube

Researchers found that although a few patients experienced improvement three months after ceasing the use of Tepezza, many continue to struggle with the adverse effects of the drug. Consequently, if you have any of these issues, we strongly encourage you to contact Atraxia Law, as our team specializes in evaluating defective drug claims. We have over 20 years of experience, and our team has the necessary knowledge and resources to point you in the right direction if you have a valid Tepezza hearing loss or tinnitus claim.

Tepezza Settlements and Litigation

In August 2022, Daniel Weibel, a resident of Arizona, filed a lawsuit against Horizon Pharmaceuticals Inc. He claims his permanent hearing loss is the consequence of having taken Tepezza between June 2020 and September 2020. Neither the man nor his physician was aware of the risk of hearing loss or tinnitus, according to the complaint. The lawsuit alleges that "numerous patient reports, scientific studies, and even Defendant's post-marketing studies have established that Tepezza causes hearing loss. Nevertheless, Defendant failed to warn, instruct, advise, educate, or otherwise inform Tepezza users." Daniel Weibel filed the lawsuit in the U.S. District Court for the Northern District of Illinois.

Despite the allegations, Horizon Therapeutics USA Inc. insists the label did warn of hearing loss. In October, the drugmaker filed a motion to dismiss the plaintiff's complaint, alleging that Daniel Weibel "fails to state plausible claims for failure to warn and design defect under Arizona law, which applies to this case" and that "punitive damages are not allowed under Arizona law because Tepezza is FDA-approved." In December, the pharmaceutical company Amgen agreed to pay $28.5 billion to acquire Horizon Therapeutics USA Inc. This may also include potential liability for a growing number of Tepezza lawsuits filed by people who developed hearing loss.

Free case evaluation

10 Minutes Over the Phone

*No fees unless compensation is obtained

How Can Atraxia Law Help?

Talking to a lawyer can be intimidating and scary. We help you understand what is involved in a claim and if you potentially qualify before we pass you on to an Attorney. Atraxia Law is the first step to see if you qualify for compensation. We have successfully helped individuals who have been involved with challenging personal injuries that have resulted in a cash payout. Our team will carefully go over your specific situation so we have a clear understanding of your needs and will determine if you meet the preliminary requirements for a claim. This process is a quick and simple phone call with one of our case managers. We look forward to hearing from you.